|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Research Article |
1 Department of Clinical Research, University of Berne, Tiefenaustrasse 120, CH-3004 Bern, Switzerland
2 Institute for Genetics, Karlsruhe Research Center, D-76021 Karlsruhe, Germany*Both authors contributed equally to this work
Author for correspondence (e-mail: andrew.ziemiecki{at}dkf3.unibe.ch)
Accepted October 2, 2001
We have previously documented the cell-type-specific and hormone-dependent expression of the EphB4 receptor in the mouse mammary gland. To investigate its role in the biology of the mammary gland, we have established transgenic mice bearing the EphB4 receptor under the control of the MMTV-LTR promoter, which represents the first transgenic mouse model to investigate the effect(s) of unscheduled expression of EphB4 in adult organisms. Transgene expression in the mammary epithelium was induced at puberty, increased during pregnancy, culminated at early lactation and persisted until day three of post-lactational involution. In contrast, expression of the endogenous EphB4 gene is downregulated during pregnancy, is essentially absent during lactation and is re-induced after day three of post-lactational involution. The unscheduled expression of EphB4 led to a delayed development of the mammary epithelium at puberty and during pregnancy. During pregnancy, less lobules were formed, these however exhibited more numerous but smaller alveolar units. Transgenic mammary glands were characterized by a fragile, irregular morphology at lactation; however, sufficient functionality was maintained to nourish the young. Transgenic mammary glands exhibited untimely epithelial apoptotic cell death during pregnancy and abnormal epithelial DNA synthesis at early post-lactational involution, indicating a disturbed response to proliferative/apoptotic signals. Mammary tumours were not observed in the EphB4 transgenic animals; however, in double transgenic animals expressing both EphB4 and the neuT genes, tumour appearance was significantly accelerated and, in contrast to neuT-only animals, metastases were observed in the lung. These results implicate EphB4 in the regulation of tissue architecture, cellular growth response and establishment of the invasive phenotype in the adult mammary gland.
Key words: Mammary gland, Mammary tumour, Apoptosis, Whole mount, Epithelial proliferation
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  D. Vaught, J. Chen, and D. M. Brantley-Sieders Regulation of Mammary Gland Branching Morphogenesis by EphA2 Receptor Tyrosine Kinase Mol. Biol. Cell, May 15, 2009; 20(10): 2572 - 2581. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Kumar, J. S. Scehnet, E. J. Ley, J. Singh, V. Krasnoperov, R. Liu, P. K. Manchanda, R. D. Ladner, D. Hawes, F. A. Weaver, et al. Preferential Induction of EphB4 over EphB2 and Its Implication in Colorectal Cancer Progression Cancer Res., May 1, 2009; 69(9): 3736 - 3745. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Pfaff, U. Fiedler, and H. G. Augustin Emerging roles of the Angiopoietin-Tie and the ephrin-Eph systems as regulators of cell trafficking J. Leukoc. Biol., October 1, 2006; 80(4): 719 - 726. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. K. Sinha, K. Mazhar, S. B. Chinn, V. K. Dhillon, L. Liu, R. Masood, D. H. Rice, and P. S. Gill The Association Between Elevated EphB4 Expression, Smoking Status, and Advanced-Stage Disease in Patients With Head and Neck Squamous Cell Carcinoma. Arch Otolaryngol Head Neck Surg, October 1, 2006; 132(10): 1053 - 1059. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Chrencik, A. Brooun, M. L. Kraus, M. I. Recht, A. R. Kolatkar, G. W. Han, J. M. Seifert, H. Widmer, M. Auer, and P. Kuhn Structural and Biophysical Characterization of the EphB4{middle dot}EphrinB2 Protein-Protein Interaction and Receptor Specificity J. Biol. Chem., September 22, 2006; 281(38): 28185 - 28192. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Kumar, J. Singh, G. Xia, V. Krasnoperov, L. Hassanieh, E. J. Ley, J. Scehnet, N. G. Kumar, D. Hawes, M. F. Press, et al. Receptor Tyrosine Kinase EphB4 Is a Survival Factor in Breast Cancer Am. J. Pathol., July 1, 2006; 169(1): 279 - 293. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Xia, S. R. Kumar, R. Masood, M. Koss, C. Templeman, D. Quinn, S. Zhu, R. Reddy, V. Krasnoperov, and P. S. Gill Up-Regulation of EphB4 in Mesothelioma and Its Biological Significance Clin. Cancer Res., June 15, 2005; 11(12): 4305 - 4315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Xia, S. R. Kumar, R. Masood, S. Zhu, R. Reddy, V. Krasnoperov, D. I. Quinn, S. M. Henshall, R. L. Sutherland, J. K. Pinski, et al. EphB4 Expression and Biological Significance in Prostate Cancer Cancer Res., June 1, 2005; 65(11): 4623 - 4632. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. K. Noren, M. Lu, A. L. Freeman, M. Koolpe, and E. B. Pasquale Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth PNAS, April 13, 2004; 101(15): 5583 - 5588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Wang, K. Cohen, Y. Shao, P. Mole, D. Dombkowski, and D. T. Scadden Ephrin receptor, EphB4, regulates ES cell differentiation of primitive mammalian hemangioblasts, blood, cardiomyocytes, and blood vessels Blood, January 1, 2004; 103(1): 100 - 109. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Jager, U. Werling, S. Rimpf, A. Jacob, and H. Schorle Transcription Factor AP-2{gamma} Stimulates Proliferation and Apoptosis and Impairs Differentiation in a Transgenic Model Mol. Cancer Res., October 1, 2003; 1(12): 921 - 929. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Mills, N. Andersson, C. V. Hong, T. S. Stappenbeck, and J. I. Gordon Molecular characterization of mouse gastric epithelial progenitor cells PNAS, November 12, 2002; 99(23): 14819 - 14824. [Abstract] [Full Text] [PDF]
|
|
